These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 782550)

  • 1. Immunological aspects of host resistance to the development and growth of cancer.
    Currie G
    Biochim Biophys Acta; 1976 Jul; 458(2):135-65. PubMed ID: 782550
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressor cells: permitters and promoters of malignancy?
    Naor D
    Adv Cancer Res; 1979; 29():45-125. PubMed ID: 382778
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro spleen leucocyte migration and phytohaemagglutinin-stimulated lymphocyte transformation of immunosuppressed mice cells. I. Cells from mice treated by thymectomy and/or rabbit anti-mouse lymphocyte serum.
    House AK; Boak JL; Draper V
    Clin Exp Immunol; 1974 May; 17(1):179-87. PubMed ID: 4549568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological interrelationships of the body and the tumor].
    Govallo VI
    Vopr Onkol; 1975; 21(10):93-102. PubMed ID: 52944
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various functions of a dual immunity system].
    Göing H
    Arzneimittelforschung; 1974 May; 24(5):819-29. PubMed ID: 4211741
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of thymus gland in the regulation of the activity of peripheral T-lymphocytes in the process of spontaneous blastogenesis in mice].
    Stankevich SA; Ogreba VI
    Biull Eksp Biol Med; 1990 Apr; 109(4):382-4. PubMed ID: 2143680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of the immunological interaction between the host and the tumor.
    Alexander P
    Can J Otolaryngol; 1975; 4(1):36-8. PubMed ID: 236816
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological functions of the thymus.
    Schlesinger M
    Isr J Med Sci; 1977 Apr; 13(4):343-6. PubMed ID: 301519
    [No Abstract]   [Full Text] [Related]  

  • 9. Humoral immunosuppressive factors.
    Cooperband SR; Nimberg R; Schmid K; Mannick JA
    Transplant Proc; 1976 Jun; 8(2):225-42. PubMed ID: 59440
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of cancer immunology.
    Ritts RE; Neel HB
    Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
    [No Abstract]   [Full Text] [Related]  

  • 11. Perinatal immunity in calves.
    Osburn BI; Stabenfeldt GH; Ardans AA; Trees C; Sawyer M
    J Am Vet Med Assoc; 1974 Feb; 164(3):295-8. PubMed ID: 4204647
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1826-38. PubMed ID: 4361978
    [No Abstract]   [Full Text] [Related]  

  • 13. Membrane aspects of neoplasia.
    Wallach DF; Knufermann H; Wunderlich F
    FEBS Lett; 1973 Jul; 33(3):275-80. PubMed ID: 4542313
    [No Abstract]   [Full Text] [Related]  

  • 14. Corynebacterium parvum as an immunotherapeutic anticancer agent.
    Scott MT
    Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammatory infiltrates of experimental mammary cancers.
    Wei WZ; Ratner S; Fulton AM; Heppner GH
    Biochim Biophys Acta; 1986 Aug; 865(1):13-26. PubMed ID: 3089280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM; Kreider JW; Bartlett GL
    Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific cellular immunity in the evolution of breast cancer].
    Lamoureux G; Poisson R
    Ann Immunol (Paris); 1977; 128(1-2):107-8. PubMed ID: 300590
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of complement receptor-bearing cells in the spleens of tumor-bearing mice.
    Epstein RS; Lopez DM; Sigel MM; Ross GD
    J Immunol; 1978 Oct; 121(4):1524-7. PubMed ID: 308966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.